Free Access
Med Sci (Paris)
Volume 29, Number 6-7, Juin–Juillet 2013
Page(s) 669 - 670
Section Forum
Published online 12 July 2013
  1. Semerano L, Boissier MC. Les anticorps monoclonaux dans les maladies immunes inflammatoires chroniques. Med Sci (Paris) 2009 ; 25 : 1108–1112. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Rigal E, Gateault P, Lebranchu Y, Hoarau C. Les complications infectieuses liées à l’utilisation des anticorps monoclonaux chez l’homme. Med Sci (Paris) 2009 ; 25 : 1135–1140. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. Maillère B, Delluc S, Ravot G. La prédiction de l’immunogénicité des protéines thérapeutiques. Med Sci (Paris) 2012 ; 28 : 82–88. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  4. Bensussan A, Bizzini B, Pouletty P, Gallo RC, Zagury D. Les kinoïdes : une nouvelle génération de vaccins thérapeutiques. Med Sci (Paris) 2008 ; 24 : 306–313. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  5. Le Buanec H, Bensussan A, Bagot M, Gallo RC, Zagury D. Active and passive anticytokine immune therapies: current status and development. Adv Immunol 2012 ; 115 : 187–227. [CrossRef] [PubMed] [Google Scholar]
  6. Uyttenhove C, van Snick J. Auto-vaccins. Med Sci (Paris) 2013 ; 29 : 425–429. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  7. Semerano L, Biton J, Delavallée L, et al. Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-α immunotherapy in human TNF-α transgenic mice depends on anti-TNF-α antibody levels. Clin Exp Immunol 2013 ; 172 : 54–62. [CrossRef] [PubMed] [Google Scholar]
  8. Zagury D, Le Buanec H, Mathian A, et al. IFNalpha kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model. Proc Natl Acad Sci USA 2009 ; 106 : 5294–5299. [CrossRef] [Google Scholar]
  9. Delavallée L, Semerano L, Assier E, et al. Active immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis. Arthritis Res Ther 2009 ; 11 : R195. [CrossRef] [PubMed] [Google Scholar]
  10. Durez P, Miranda P, Toncheva A, et al. Active immunization with TNF-kinoid in rheumatoid arthritis patients with secondary resistance to tumor necrosis factor-alpha antagonists is safe, immunogenic. ACR 2012. Whashington DC. Arthritis Rheum 2012 ; 64 : S209. [Google Scholar]
  11. Rogler G, Michetti P, Kruger F, van der Bijl A. Active therapeutic immunization against TNF with a TNF-kinoid in Crohn’s disease patients: a phase 1–2 study. Chicago : DDW, 2011 : T1234. [Google Scholar]
  12. Lauwerys BR, Hachulla E, Spertini F, et al. Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid. Arthritis Rheum 2013 ; 65 : 447–456. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.